Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeover, Buy Back and De-listing vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13,2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017,20190424-35 dated April 24,2019 and 20200528-32 dated 28 May 2020, 20201102-43 dated 02 Nov 2020, 20210825-62 dated Aug 25,2021 has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.
All market participants are hereby informed that an Open Offer is made by M/s. Lenus Finvest Private Limited (“Acquirer 1”), Mr. Siddhant Laxmikant Kabra (“Acquirer 2”), Mr. Laxmikant Ramprasad Kabra (“Acquirer 3”), Mr. Bhavesh Dhirajlal Tanna (“Acquirer 4”) and M/s. Laxmikant Ramprasad Kabra HUF ("Acquirer 5") (Hereinafter jointly referred as "Acquirers") to the Public Shareholders of EIKO LIFESCIENCES LIMITED (“Target Company”) to acquire up to 36,03,716 (Thirty Six Lakhs Three Thousand Seven Hundred & Sixteen )equity shares of face value of each representing 26.00% of Expanded Voting Share Capital of the Target Company at a price of Rs.53.10/- (Rupees Fifty Three & Ten Paise Only)(The Amount of Rs 31.50/-per equity share remaining unpaid on 14,10,894 partly paid up equity shares (of which Rs 7/-per equity share is towards face value and Rs 24.50 per equity share is towards share premium)if any tendered in the offer shall be adjusted against the offer price of Rs 53.10/-per offer share & the balance amount of Rs 21.60/-per offer share alone shall be paid to such shareholder who may tender their partly paid -up equity shares in this offer) payable in cash, pursuant to and in compliance with Regulations 3(1) and 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments there to (“SEBI (SAST) Regulations”), for substantial acquisition of Equity Shares and Voting Share Capital accompanied with change in control and management of the Target Company from Wednesday, October 09, 2024 to Tuesday ,October 22, 2024.
Letter of Offer is herewith attached for your perusal.
Market participants are further requested to note that this offer will be as per the Revised Guidelines of SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017 and 20190424-35 dated April 24, 2019 along with the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.
Mangesh Tayde
Deputy General Manager
Listing Business Relationship
October 07, 2024 |